Lixte Stock Future Price Prediction

LIXT -  USA Stock  

USD 2.05  0.05  2.50%

Lixte Biotech Hlds stock price prediction is an act of determining the future value of Lixte Biotech shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Lixte Biotech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Lixte Biotech and does not consider all of the tangible or intangible factors available from Lixte Biotech's fundamental data. We analyze noise-free headlines and recent hype associated with Lixte Biotech Hlds, which may create opportunities for some arbitrage if properly timed.
Additionally, see Lixte Biotech Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Lixte Biotech based on different types of headlines from major news networks to social media. The Lixte stock price prediction module provides an analysis of price elasticity to changes in media outlook on Lixte Biotech over a specific investment horizon. Using Lixte Biotech hype-based prediction, you can estimate the value of Lixte Biotech Hlds from the perspective of Lixte Biotech response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Lixte Biotech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Lixte Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Lixte because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lixte Biotech after-hype prediction price

    
  $ 2.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Lixte Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Lixte Biotech in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.132.536.31
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lixte Biotech. Your research has to be compared to or analyzed against Lixte Biotech's peers to derive any actionable benefits. When done correctly, Lixte Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Lixte Biotech Hlds.

Lixte Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of Lixte Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lixte Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Lixte Biotech, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Lixte Biotech Estimiated After-Hype Price Volatility

In the context of predicting Lixte Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lixte Biotech's historical news coverage. Lixte Biotech's after-hype downside and upside margins for the prediction period are 0.10 and 5.78, respectively. We have considered Lixte Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.05
22nd of September 2021
2.00
After-hype Price
5.78
Upside
Lixte Biotech is risky asset. Analysis and calculation of next after-hype price of Lixte Biotech Hlds is based on 3 months time horizon.

Lixte Biotech Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Lixte Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lixte Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lixte Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.49  4.07  0.01   2.03  1 Events / Month3 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.052.000.00 
20,350  

Lixte Biotech Hype Timeline

Lixte Biotech Hlds is now traded for 2.05. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 2.03. Lixte anticipated not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of over 100%. The immediate return on the next newsis anticipated to be very small whereas the daily expected return is now at -0.49%. The volatility of relative hype elasticity to Lixte Biotech is about 98.23%. The volatility of related hype on Lixte Biotech is about 98.23% with expected price after next announcement by competition of 4.08. About 68.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.29. Lixte Biotech Hlds had not issued any dividends in recent years. The entity had 1-6 split on the 20th of November 2020. Given the investment horizon of 90 days the next anticipatedpress releasewill be very soon.
Additionally, see Lixte Biotech Basic Forecasting Models to cross-verify your projections.

Lixte Biotech Related Hype Analysis

Having access to credible news sources related to Lixte Biotech's direct competition is more important than ever and may enhance your ability to predict Lixte Biotech's future price movements. Getting to know how Lixte Biotech rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lixte Biotech may potentially react to the hype associated with one of its peers.

Lixte Biotech Additional Predictive Modules

Most predictive techniques to examine Lixte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lixte using various technical indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lixte Biotech Predictive Indicators

The successful prediction of Lixte Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lixte Biotech Hlds, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lixte Biotech based on analysis of Lixte Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lixte Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lixte Biotech's related companies.

Story Coverage note for Lixte Biotech

The number of cover stories for Lixte Biotech depends on current market conditions and Lixte Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lixte Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lixte Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Lixte Biotech Short Properties

Lixte Biotech's future price predictability will typically decrease when Lixte Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lixte Biotech Hlds often depends not only on the future outlook of the potential Lixte Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lixte Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.22%
Short Percent Of Float0.49%
Float Shares3.84M
Shares Short Prior Month30.36k
Average Daily Volume Last 10 Day36.71k
Average Daily Volume In Three Month394.29k
Date Short Interest28th of May 2021
Additionally, see Lixte Biotech Basic Forecasting Models to cross-verify your projections. Note that the Lixte Biotech Hlds information on this page should be used as a complementary analysis to other Lixte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Lixte Stock analysis

When running Lixte Biotech Hlds price analysis, check to measure Lixte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotech is operating at the current time. Most of Lixte Biotech's value examination focuses on studying past and present price action to predict the probability of Lixte Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lixte Biotech's price. Additionally, you may evaluate how the addition of Lixte Biotech to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
The market value of Lixte Biotech Hlds is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotech's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotech's market value can be influenced by many factors that don't directly affect Lixte Biotech Hlds underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Lixte Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.